Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Having personally tested ...

Ban due to take effect next week, but Meta has started deactivating accounts already Australia’s world-first social media ban begins Australian social media ban explained: everything you need to know ...